The Ohio State University
Bioheart Partnership With Stemlogix Leads to First in U.S. Combination ...SYS-CON Media (press release)QB) previously announced that its cGMP facility would be utilized by Stemlogix to help promote regenerative medicine for the veterinary market. Stemlogix has just announced the first ever combination regenerative medicine treatment on a six-year-old ...See all stories on this topic »
